Request Demo
Last update 20 Apr 2026
Shanghai Chia Tai Tianqing Pharmaceutical Tech Dev Co. Ltd.
Subsidiary Company|2022|Shanghai Shi, China
Subsidiary Company|2022|Shanghai Shi, China
Last update 20 Apr 2026
Overview
Tags
Neoplasms
Hemic and Lymphatic Diseases
Respiratory Diseases
Monoclonal antibody
Small molecule drug
Antibody drug conjugate (ADC)
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20244467
评价 TQC2731 注射液在中度至极重度慢性阻塞性肺疾病患者的有效性、安全性和药代动力学的多中心、随机、双盲、安慰剂对照 Ⅱ 期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase II clinical trial evaluating the efficacy, safety, and pharmacokinetics of TQC2731 injection in patients with moderate to very severe chronic obstructive pulmonary disease.
CTR20252325
评价TQC2731注射液在青少年哮喘患者中多次给药后的药代动力学、安全性、耐受性和免疫原性的Ib/II期研究
[Translation] A Phase Ib/II Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Immunogenicity of TQC2731 Injection in Adolescents with Asthma Following Repeated Dosing
100 Clinical Results associated with Shanghai Chia Tai Tianqing Pharmaceutical Tech Dev Co. Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shanghai Chia Tai Tianqing Pharmaceutical Tech Dev Co. Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Chia Tai Tianqing Pharmaceutical Tech Dev Co. Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 29 Apr 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Application
3
1
IND Approval
Phase 2
1
1
Phase 3
Approved
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free